Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7967353rdf:typepubmed:Citationlld:pubmed
pubmed-article:7967353lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7967353lifeskim:mentionsumls-concept:C0232804lld:lifeskim
pubmed-article:7967353lifeskim:mentionsumls-concept:C2709270lld:lifeskim
pubmed-article:7967353lifeskim:mentionsumls-concept:C0206473lld:lifeskim
pubmed-article:7967353lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7967353lifeskim:mentionsumls-concept:C1514761lld:lifeskim
pubmed-article:7967353pubmed:issue2lld:pubmed
pubmed-article:7967353pubmed:dateCreated1994-12-12lld:pubmed
pubmed-article:7967353pubmed:abstractTextTo identify the contribution of natriuretic peptide (NP) activity to the adaptative increases in glomerular filtration rate (GFR), effective renal plasma flow rate (ERPF) and fractional sodium excretion (FENa) observed in the remnant kidney, we investigated the acute effects of administering HS-142-1 (HS), a potent NP receptor antagonist, in 5/6th nephrectomized (NPX) rats. In addition to normal sodium intake, high or low sodium intakes were used to stimulate or suppress, respectively, endogenous NP activity in NPX rats. In rats three days after NPX on high sodium, HS (20 mg/kg bolus i.v.) reduced GFR from 0.55 +/- 0.05 to 0.35 +/- 0.04 ml/min; ERPF from 1.83 +/- 0.19 to 1.53 +/- 0.16 ml/min; and FENa from 7.1 +/- 1.1 to 1.6 +/- 0.4%, without affecting MAP. Similar changes of lesser magnitude were observed in NPX rats on normal sodium intake. By contrast, GFR, ERPF, FENa and MAP were unchanged following HS in NPX rats on low sodium intake, suggesting that the magnitude of responses to HS is dependent upon the expected levels of activity of NP. We conclude that in anesthetized rats, natriuretic peptides contribute to the compensatory increases in GFR, ERPF and FENa observed in the remnant kidney under normal and salt-replete conditions.lld:pubmed
pubmed-article:7967353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:languageenglld:pubmed
pubmed-article:7967353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:citationSubsetIMlld:pubmed
pubmed-article:7967353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7967353pubmed:statusMEDLINElld:pubmed
pubmed-article:7967353pubmed:monthAuglld:pubmed
pubmed-article:7967353pubmed:issn0085-2538lld:pubmed
pubmed-article:7967353pubmed:authorpubmed-author:TroyJ LJLlld:pubmed
pubmed-article:7967353pubmed:authorpubmed-author:BrennerB MBMlld:pubmed
pubmed-article:7967353pubmed:authorpubmed-author:ZhangP LPLlld:pubmed
pubmed-article:7967353pubmed:authorpubmed-author:MackenzieH...lld:pubmed
pubmed-article:7967353pubmed:issnTypePrintlld:pubmed
pubmed-article:7967353pubmed:volume46lld:pubmed
pubmed-article:7967353pubmed:ownerNLMlld:pubmed
pubmed-article:7967353pubmed:authorsCompleteYlld:pubmed
pubmed-article:7967353pubmed:pagination414-20lld:pubmed
pubmed-article:7967353pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:meshHeadingpubmed-meshheading:7967353-...lld:pubmed
pubmed-article:7967353pubmed:year1994lld:pubmed
pubmed-article:7967353pubmed:articleTitleEffects of natriuretic peptide receptor inhibition on remnant kidney function in rats.lld:pubmed
pubmed-article:7967353pubmed:affiliationDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.lld:pubmed
pubmed-article:7967353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7967353pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed